Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

George Galvan

Neurological Surgery San Antonio, TX Medical Doctor

NPI 1255512539 CMS profile 328757

24165 W Ih 10, Ste 123, San Antonio, TX 78257

Open in the dashboard

General payments

$82,643

825 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, George Galvan of San Antonio, TX is reported in the CMS Open Payments database as having received $82,643 across 825 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 90th percentile of Neurological Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $27,973 126
2024 General $8,839 93
2023 General $12,251 97
2022 General $11,114 113
2021 General $2,859 138
2020 General $6,767 135
2019 General $12,841 123

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • George Galvan
  • Neurological Surgery median
  • Middle half of Neurological Surgery
  • National median

In program year 2025, general payments to George Galvan were reported at $27,973. Among 5,467 Neurological Surgery profiles paid that year, the median was $596 and the middle half received between $159 and $3,102.

Show as a table
Year George Galvan Neurological Surgery median Middle half National median
2019 $12,841 $582 $138–$3,006 $163
2020 $6,767 $294 $76–$2,174 $114
2021 $2,859 $387 $105–$2,432 $132
2022 $11,114 $542 $139–$2,989 $149
2023 $12,251 $534 $145–$2,697 $160
2024 $8,839 $574 $155–$3,046 $164
2025 $27,973 $596 $159–$3,102 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Nevro Corp. $24,090 187 payments
  2. Abbott Laboratories $22,185 361 payments
  3. Globus Medical, Inc. $13,617 45 payments
  4. BIOTRONIK NRO, Inc. $11,053 12 payments
  5. Medtronic, Inc. $3,143 63 payments
  6. Painteq LLC $2,401 33 payments
  7. SI-BONE, Inc. $1,938 35 payments
  8. Boston Scientific Corporation $819 20 payments
  9. Medtronic USA, Inc. $763 13 payments
  10. Mission Medical Distribution, LLC $435 3 payments
  11. Other $2,199 53 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $23,363 764 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $21,378 8 payments
  3. Consulting Fee $14,315 4 payments
  4. Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program $9,625 6 payments
  5. Compensation for serving as faculty or as a speaker for a medical education program $7,650 5 payments
  6. Travel and Lodging $5,475 32 payments
  7. Education $839 6 payments
Products named General payments · program years 2019–2025
  1. PROCLAIM $18,118 119 payments
  2. Vyrsa V1 $16,873 17 payments
  3. Senza Spinal Cord Stimulation System $15,849 106 payments
  4. Prospera $10,943 12 payments
  5. PAINTEQ $2,401 33 payments
  6. Senza Spinal Cord Stimulator $1,572 36 payments
  7. INTELLIS ADAPTIVESTIM $1,553 11 payments
  8. Senza Spinal Cord Stimulator $1,449 31 payments
  9. Omnia $1,269 38 payments
  10. IFUSE IMPLANT $1,209 20 payments
  11. Other $8,809 372 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 3 drugs

Part D claims

64

Median for Neurosurgery: 83

Drug cost

$472

Median for Neurosurgery: $872

Branded share of claims

78.1%

Median for Neurosurgery: 16.5%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 35 $319
Acetaminophen-Codeine Acetaminophen With Codeine Brand 15 $115
Tramadol Hcl Generic 14 $37

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 2,779 Part D prescribers listed as Neurosurgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 46 billing codes

Paid by Medicare

$112,631

Medicare's payments for the services billed

Medicare patients

257

Average age 73

Services billed

544

131 women, 126 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Diabetes 40%
Ischemic heart disease 34%
Chronic kidney disease 30%
Depression 28%
COPD 17%
Atrial fibrillation 16%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

825 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Neurological Surgery in Texas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record